1,363
Views
4
CrossRef citations to date
0
Altmetric
Letter to the Editor

VLA-4 and CXCR4 overexpression in bone marrow of an aleukemic B-cell acute lymphoblastic leukemia presenting with osteolytic bone lesions

, , , , , , , , & show all
Pages 2465-2467 | Received 28 Oct 2014, Accepted 09 Dec 2014, Published online: 09 Feb 2015

References

  • Karremann M, Schreiner U, Busing KA, et al. [Acute lymphoblastic leukemia presenting without peripheral blasts but with osteolysis and hypercalcemia in an adolescent. Atypical but not rare]. Orthopade 2009;38:752–754.
  • Lu X, Mu E, Wei Y, et al. VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging alpha4beta1-positive osteoclast progenitors. Cancer Cell.2011;20: 701–714.
  • Pereira JP, An J, Xu Y, et al. Cannabinoid receptor 2 mediates the retention of immature B cells in bone marrow sinusoids. Nat Immunol 2009;10:403–411.
  • Park SY, Wolfram P, Canty K, et al. Focal adhesion kinase regulates the localization and retention of pro-B cells in bone marrow microenvironments. J Immunol 2013;190:1094–1102.
  • Peled A, Kollet O, Ponomaryov T, et al. The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice. Blood 2000;95:3289–3296.
  • Ma Q, Jones D, Springer TA. The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment. Immunity 1999;10: 463–471.
  • Diamond P, Labrinidis A, Martin SK, et al. Targeted disruption of the CXCL12/CXCR4 axis inhibits osteolysis in a murine model of myeloma-associated bone loss. J Bone Miner Res 2009;24:1150–1161.
  • Zeng RM, Jin DD, Zhang ZM. [Induced differentiation of human peripheral blood CD68 + mononuclear cells into osteoclasts in vitro]. Di Yi Jun Yi Da Xue Xue Bao 2004;24:585–588.
  • Ashley JW, Shi Z, Zhao H, et al. Genetic ablation of CD68 results in mice with increased bone and dysfunctional osteoclasts. PloS One 2011;6:e25838.
  • Zannettino AC, Farrugia AN, Kortesidis A, et al. Elevated serum levels of stromal-derived factor-1alpha are associated with increased osteoclast activity and osteolytic bone disease in multiple myeloma patients. Cancer Res 2005;65:1700–1709.
  • Jacobsen K, Kravitz J, Kincade PW, et al. Adhesion receptors on bone marrow stromal cells: in vivo expression of vascular cell adhesion molecule-1 by reticular cells and sinusoidal endothelium in normal and gamma-irradiated mice. Blood 1996;87:73–82.
  • Glodek AM, Honczarenko M, Le Y, et al. Sustained activation of cell adhesion is a differentially regulated process in B lymphopoiesis. J Exp Med 2003;197:461–473.
  • Mansour A, Anginot A, Mancini SJ, et al. Osteoclast activity modulates B-cell development in the bone marrow. Cell Res 2011;21:1102–1115.